Zoetis

FDA | April 24, 2020

The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems. The decades-old drug has been called a “game changer” by Trump in the fight against the novel coronavirus and anecdotal reports that it may provide some benefit have spurred sales of the drug. Within hours of Trump&rsquo...

HEALTH TECHNOLOGY

REVIV | December 14, 2020

Because of worries over the Government's contact tracing framework and the struggling organizations in the UK, Sarah Lomas, the President and CEO of REVIV, devoted the organization's endeavors to give an answer to the UK as well as across the world. In a joint effort with a bleeding edge advancement group, driven by tech master Idan Udi Edry, REVIV has made HELIIX - the most strong and successful management prog...

HealtheMed | September 18, 2020

HealtheMed today announces the launch of its new telemedicine platform to bring healthcare into the homes of the most vulnerable Minnesota Medicaid populations. HealtheMed has closed a seed round of capital from angel investors to fuel the launch of its new service and expansion to markets across the United States. HealtheMed’s unique platform will enable Medicaid special needs populations to quickly access medica...

HEALTH TECHNOLOGY

CrossTx | November 02, 2021

Behavioral health care workers continue to see a rise in mental health concerns as the COVID-19 pandemic continues to provoke Americans' levels of psychological and emotional distress. The Centers for Medicare and Medicaid Services (CMS) has identified the mission-critical importance of integrating behavioral health with primary care, widely understood as an effective strategy for improving the outcomes of millions of Americans experiencing mental or behavioral health issues. ...